Patent · US Active

Engineered Cas9 nucleases

US10428319B2 · kind B2 · utility

9Cited by
52References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 8, 2018
Grant dateOct 1, 2019
Priority date—
Expiry dateJun 8, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2800/80
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present disclosure relates to Cas9 nuclease variants and methods of producing and using such variants.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.